{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T06:08:41Z","timestamp":1779170921109,"version":"3.51.4"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Object<\/jats:title>\n                    <jats:p>To report the clinical and genetic characteristics of patients diagnosed with pseudohypoparathyroidism (PHP) or inactivating parathyroid hormone (PTH)\/PTHrP signaling disorders (iPPSD), and to provide insights for the diagnosis and management of this rare inherited metabolic disorder.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study focused on two patients diagnosed with PHP or iPPSD, aiming to investigate their clinical and genetic characteristics. Clinical manifestations and biochemical indicators of the two subjects were collected and analyzed. Whole-exome sequencing was employed to detect potential genetic mutations associated with the disorder. Additionally, pedigree analysis was performed to clarify the inheritance pattern of the identified mutation in the families of the two patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Both patients presented with recurrent seizures and Albright\u2019s hereditary osteodystrophy (AHO) features. Biochemical tests revealed consistent abnormalities in both subjects, including hypocalcemia, hyperphosphatemia, and elevated levels of PTH and thyroid-stimulating hormone (TSH). Whole-exome sequencing successfully isolated a specific four-nucleotide deletion (GACT) within exon 7 of the\n                      <jats:italic>GNAS<\/jats:italic>\n                      gene, confirming the condition as iPPSD2. Pedigree analysis verified that the mutation was maternally inherited in both families; however, the clinical presentation of the mutation varied among relatives in each family.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The symptoms of iPPSD are inconsistent and easily misidentified, which highlights the necessity of early genetic screening and PTH monitoring for patients with AHO-like physical traits or electrolyte imbalances. Precise molecular diagnosis is vital for ensuring effective and timely clinical intervention, as well as for preventing long-term complications associated with this rare metabolic disorder. This study provides valuable clinical and genetic data to enhance the understanding and management of PHP\/iPPSD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1800965","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T05:41:01Z","timestamp":1779169261000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Familial investigation of two cases of pseudohypoparathyroidism"],"prefix":"10.3389","volume":"17","author":[{"given":"Huihui","family":"Yin","sequence":"first","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Dalian Medical University","place":["Dalian, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuenan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Dalian Medical University","place":["Dalian, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meixuan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Dalian Medical University","place":["Dalian, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiawen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Dalian Medical University","place":["Dalian, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Dalian Medical University","place":["Dalian, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianling","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Dalian Medical University","place":["Dalian, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haicheng","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Dalian Medical University","place":["Dalian, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Men","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The First Affiliated Hospital of Dalian Medical University","place":["Dalian, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1530\/endoabs.56.gp175","article-title":"Diagnosis and management of pseudohypoparathyroidism and related disorders: first international consensus statement","volume":"14","author":"Mantovani","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2018.07.011","article-title":"Pseudohypoparathyroidism","volume":"47","author":"Linglart","year":"2018","journal-title":"Endocrinol Metab Clin"},{"key":"B3","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/eje-15-0628","article-title":"European society of endocrinology clinical guideline: treatment of chronic hypoparathyroidism in adults","volume":"173","author":"Bollerslev","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-67199-4_101631","article-title":"The GNAS complex locus and human diseases associated with loss-of-function mutations or epimutations within this imprinted gene","volume":"80","author":"Turan","year":"2013","journal-title":"Horm Res Paediatr"},{"key":"B5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1359\/jbmr.2000.15.11.2084","article-title":"Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia","volume":"346","author":"Shore","year":"2002","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/humu.22696","article-title":"GNAS mutations in pseudohypoparathyroidism type 1a and related disorders","volume":"36","author":"Lemos","year":"2015","journal-title":"Hum Mutat"},{"key":"B7","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1530\/eje-16-0107","article-title":"From pseudohypoparathyroidism to inactivating PTH\/PTHrP signalling disorder (iPPSD), a novel classification proposed by the EuroPHP network","volume":"175","author":"Thiele","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/med.0000000000000306","article-title":"Nonclassic features of pseudohypoparathyroidism type 1A","volume":"24","author":"Shoemaker","year":"2017","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab208","article-title":"Pseudohypoparathyroidism: focus on cerebral and renal calcifications","volume":"106","author":"Mazoni","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1515\/jpem.2006.19.s2.671","article-title":"Albright\u2019s hereditary osteodystrophy","volume":"31","author":"Wilson","year":"1994","journal-title":"J Med Genet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1304232","article-title":"GNAS epigenetic defects and pseudohypoparathyroidism: time for a new classification","volume":"44","author":"Mantovani","year":"2012","journal-title":"Horm Metab Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090640","article-title":"Mutations in pseudohypoparathyroidism 1a and pseudopseudohypoparathyroidism in ethnic chinese","volume":"9","author":"Wu","year":"2014","journal-title":"PloS One"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.11.4127","article-title":"Resistance to the lipolytic action of epinephrine: a new feature of protein gs deficiency","volume":"84","author":"Carel","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2000.00911","article-title":"Pseudohypoparathyroidism--another monogenic obesity syndrome","volume":"52","author":"Ong","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.3.824","article-title":"Reproductive dysfunction in women with albright\u2019s hereditary osteodystrophy","volume":"83","author":"Namnoum","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1649","article-title":"Recombinant human GH replacement therapy in children with pseudohypoparathyroidism type ia: first study on the effect on growth","volume":"95","author":"Mantovani","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/mop.0000000000000783","article-title":"Management of pseudohypoparathyroidism","volume":"31","author":"Germain-Lee","year":"2019","journal-title":"Curr Opin Pediatr"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145544","article-title":"Disposable soma theory and the evolution of maternal effects on ageing","volume":"11","author":"van den Heuvel","year":"2016","journal-title":"PloS One"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1159\/000491045","article-title":"Parathyroid hormone resistance syndromes - inactivating PTH\/PTHrP signaling disorders (iPPSDs)","volume":"32","author":"Elli","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1530\/eje-20-0625","article-title":"Inactivating PTH\/PTHrP signaling disorders (iPPSDs): evaluation of the new classification in a multicenter large series of 544 molecularly characterized patients","volume":"184","author":"Pereda","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpurol.2014.10.003","article-title":"Environmental, parental and gestational factors that influence the occurrence of hypospadias in Male patients","volume":"11","author":"Marrocco","year":"2015","journal-title":"J Pediatr Urol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1800965\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T05:41:05Z","timestamp":1779169265000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1800965\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":21,"alternative-id":["10.3389\/fendo.2026.1800965"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1800965","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"article-number":"1800965"}}